COYA · Coya Therapeutics, Inc. · Documents
Market Cap
$98.76M
Shares
23.46M
Volume · Oct 20
82.91K
Avg daily vol (3M)
137.74K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | Coya Therapeutics’ placebo-controlled All-Stars Phase 2 has enrolled 120 patients in an ALS trial of low-dose IL-2 with CTLA-4; top-line data are expected in Q2, and an FTD trial is planned for 2027. | 2026-10-20 | 2026-12-31 | |
| 8-K | Coya Therapeutics, Inc. plans to begin the Phase 2/3 ALSTARS Trial open-label extension in November 2026, while shifting the planned COYA 302 frontotemporal dementia Phase 2 trial to 2027; cash runway remains into the second half of 2027. | 2026-10-14 | — | |
| 8-K | — | 2026-10-05 | — | |
| 8-K | — | 2026-09-15 | — | |
| 8-K | — | 2026-08-11 | — | |
| 10-Q | — | 2026-08-11 | 2026-06-30 | |
| 8-K/A | — | 2026-08-07 | 2026-03-29 | |
| 8-K | — | 2026-06-25 | — | |
| ARS | — | 2026-05-13 | 2025-12-31 | |
| DEFA14A | — | 2026-05-13 | — | |
| DEF 14A | — | 2026-05-13 | 2026-06-25 | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-12 | — | |
| 8-K | — | 2026-05-12 | — | |
| 8-K | — | 2026-04-02 | 2026-03-29 | |
| 10-K | — | 2026-03-16 | 2025-12-31 | |
| S-3 | — | 2026-03-16 | — | |
| 8-K | — | 2026-03-16 | — | |
| 8-K | — | 2026-01-30 | 2026-01-29 | |
| 8-K | — | 2026-01-20 | — | |
| 8-K | — | 2026-01-08 | — | |
| 8-K | — | 2025-12-17 | 2025-12-16 | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-12 | — | |
| 8-K | — | 2025-10-27 | 2025-10-23 | |
| 8-K | — | 2025-09-02 | 2025-08-29 | |
| S-3 | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-07-29 | — | |
| 8-K | — | 2025-07-01 | 2025-06-30 | |
| 8-K | — | 2025-06-26 | — | |
| DEFA14A | — | 2025-05-16 | — | |
| ARS | — | 2025-05-16 | 2024-12-31 | |
| DEF 14A | — | 2025-05-16 | 2025-06-26 | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| 10-K/A | — | 2025-04-28 | 2024-12-31 | |
| 8-K | — | 2025-03-18 | — | |
| 10-K | — | 2025-03-18 | 2024-12-31 | |
| S-3 | — | 2024-11-20 | — | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-11-06 | — | |
| 8-K | — | 2024-11-05 | 2024-11-01 | |
| 8-K | — | 2024-10-31 | 2024-10-28 | |
| 8-K | — | 2024-10-29 | — | |
| 8-K | — | 2024-10-22 | 2024-10-21 | |
| 8-K | — | 2024-08-19 | 2024-08-16 | |
| 8-K | — | 2024-08-12 | — | |
| 10-Q | — | 2024-08-12 | 2024-06-30 |
Showing 1–50 of 94 filings